🇺🇸 FDA
Patent

US 11485976

Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same

granted A61KA61K2039/505A61K2039/52

Quick answer

US patent 11485976 (Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EnGeneIC Molecular Delivery Pty Ltd
Grant date
Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K2039/52, A61K2039/55561, A61K35/74